Invitae: Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

(marketscreener.com) - Ciitizen real-world data platform expansion helps advance research and potentially improve outcomes for patients with pediatric epilepsy and/or developmental delay - SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- Invitae , a leading medical genetics company, today announced the launch of the Rare Patient Network expanding...https://www.marketscreener.com/quote/stock/INVITAE-CORPORATION-23400709/news/Invitae-Launches-Rare-Patient-Network-for-Pediatric-Patients-With-Rare-Neurodevelopmental-Diseases-42452972/?utm_medium=RSS&utm_content=20221201